Las Vegas Valley Water District, NV Limited-Tax GO Bonds Assigned 'AA+' Rating Jul 09

  • ID: 1785818
  • July 2009
  • Standard & Poors
1 of 3

SAN FRANCISCO (Standard & Poor's) July 16, 2009--Standard & Poor's Ratings Services assigned its 'AA+' rating to Las Vegas Valley Water District, Nev.'s $90 million limited-tax general obligation (GO) water bonds, series 2009A (taxable direct-pay Build America Bonds), and its 'AA+' rating to the district's $10 million limited-tax GO water bonds, series 2009B (tax-exempt). At the same time, Standard & Poor's affirmed its 'AA+' long-term rating and underlying rating (SPUR) on the district's outstanding GO bonds. The outlook is stable. "The rating is based on the district's critical role as the sole water wholesale entity serving Nevada's largest metropolitan area," said Standard & Poor's credit analyst Paul Dyson. "We believe that the district will manage through the current economic and...

Companies mentioned in this report are:
- Las Vegas Vy Wtr Dist

Action: Affirmed
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Las Vegas Vy Wtr Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.